Scholar Rock Holding (SRRK) Profit After Tax (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Profit After Tax of -$105.5 million in Q1 2026, down 15.99% quarter-over-quarter from -$91.0 million in Q4 2025, and down 41.2% on a YoY basis from -$179.4 million in Q1 2025.

Scholar Rock Holding (SRRK) Profit After Tax (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Profit After Tax history runs 10 years deep, the most recent figure standing at -$105.5 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 41.2% year-over-year to -$105.5 million; the TTM figure through Mar 2026 stood at -$408.7 million (down 54.72% YoY), while the FY2025 annual figure was -$377.9 million, down 53.45% from the prior year.
  • Profit After Tax was -$105.5 million for Q1 2026 at Scholar Rock Holding, down from -$91.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$8.0 million in Q1 2022 to a low of -$110.0 million in Q2 2025.
  • Historically, Profit After Tax has averaged -$60.6 million across 5 years, with a median of -$56.9 million in 2024.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax jumped 71.27% in 2022, then plunged 395.33% in 2023.
  • A 5-year view of Profit After Tax shows it stood at -$39.3 million in 2022, then retreated by 17.5% to -$46.1 million in 2023, then slumped by 44.07% to -$66.5 million in 2024, then plunged by 36.88% to -$91.0 million in 2025, then declined by 15.99% to -$105.5 million in 2026.
  • The last three Profit After Tax figures came in at -$105.5 million (Q1 2026), -$91.0 million (Q4 2025), and -$102.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.90 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.63 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -753,254.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.74 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -105.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -105.51 Mn
Dec 31, 2025 -90.97 Mn
Sep 30, 2025 -102.22 Mn
Jun 30, 2025 -110.03 Mn
Mar 31, 2025 -74.72 Mn
Dec 31, 2024 -66.45 Mn
Sep 30, 2024 -64.48 Mn
Jun 30, 2024 -58.51 Mn
Mar 31, 2024 -56.85 Mn
Dec 31, 2023 -46.13 Mn
Sep 30, 2023 -42.36 Mn
Jun 30, 2023 -37.93 Mn
Mar 31, 2023 -39.38 Mn
Dec 31, 2022 -39.26 Mn
Sep 30, 2022 -43.30 Mn
Jun 30, 2022 -44.00 Mn
Mar 31, 2022 -7.95 Mn
Dec 31, 2021 -35.91 Mn
Sep 30, 2021 -37.51 Mn
Jun 30, 2021 -30.71 Mn